7-Ethoxycoumarin

CAS No. 31005-02-4

7-Ethoxycoumarin( —— )

Catalog No. M21250 CAS No. 31005-02-4

7-Ethoxycoumarin a typical human P450 substrate is catalyzed by both wild-type and mutant forms of CYP102A1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 43 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    7-Ethoxycoumarin
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Ethoxycoumarin a typical human P450 substrate is catalyzed by both wild-type and mutant forms of CYP102A1.
  • Description
    7-Ethoxycoumarin a typical human P450 substrate is catalyzed by both wild-type and mutant forms of CYP102A1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    31005-02-4
  • Formula Weight
    190.19
  • Molecular Formula
    C11H10O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (525.76 mM)
  • SMILES
    CCOc(cc1)cc(O2)c1C=CC2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tomohide Uno Ryosuke et al. Metabolism of 7-ethoxycoumarin flavanone and steroids by cytochrome P450 2C9 variants.[J]. Biopharmaceutics & Drug Disposition 2017.
molnova catalog
related products
  • Cbz-NH-PEG1-CH2COOH

    Cbz-NH-PEG1-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • Licorice glycoside C...

    Licorice glycoside C2 is a oleanane-type triterpene oligoglycoside isolated from Glycyrrhiza uralensis. Various biological activities are associated with licorice extracts, such as anti-viral, anti-microbial, antioxidant, anti-inflammatory, anti-ulcer, anti-cancer and anti-HIV effects.

  • TCV-309 chloride

    A highly potent and selective platelet activating factor (PAF) antagonist; inhibits PAF-induced aggregation of rabbit and human platelets with IC50s of 33 nM and 55 nM respectively.